PLSE PEER ANALYSIS

Pulse Biosciences Inc — metric-by-metric comparison with peers and the industry median

PLSEPulse Biosciences Inc

🇺🇸 USA · NASDAQ · Healthcare · Medical Instruments & Supplies

Value it Duel

Overall Profile & Returns

· Medical Instruments & Supplies

Position Within Industry

0 = weak quartile, 100 = strong quartile

PLSEIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	PLSE	ANN	FPH	RMD	CTEC	EL	Ind. Median
P/E	—	24.16	41.27	20.35●	34.11	34.91	34.91
P/B	29.86	1.66●	9.08	4.73	3.94	2.08	2.95
EV/EBITDA	—	12.52	23.29	13.83	11.98●	14.01	14.72
P/S	2,636.18	1.58●	8.27	5.56	2.45	2.84	2.79

Financial Health
Metric	PLSE	ANN	FPH	RMD	CTEC	EL	Ind. Median
Current Ratio	7.26●	2.36	2.31	3.01	1.53	0.99	2.40
Debt/Equity	10.8%	46.2%	6.9%●	13.0%	100.0%	37.0%	34.8%
NetDebt/EBITDA	0.83	2.10	-0.39●	-0.38	2.33	1.66	1.44

Profitability
Metric	PLSE	ANN	FPH	RMD	CTEC	EL	Ind. Median
Net Margin	-9,929.0%	6.7%	20.0%	27.4%●	7.2%	8.1%	3.9%
ROE	-80.7%	7.2%	23.3%	25.2%●	10.9%	5.8%	2.3%
ROA	-69.4%	4.2%	17.3%	18.6%●	4.8%	3.6%	1.5%
EBITDA Margin	-9,866.7%	15.2%	34.9%	39.1%●	25.3%	23.0%	13.8%

Growth + Dividend
Metric	PLSE	ANN	FPH	RMD	CTEC	EL	Ind. Median
Rev. Growth	-69.9%	11.4%●	4.8%	10.5%	6.8%	7.5%	6.4%
NI Growth	—	23.8%●	-11.6%	15.9%	-8.0%	-1.8%	14.0%
Div. Yield	—	1.7%	1.6%	8.0%●	3.3%	2.3%	1.7%
Payout	—	53.2%	53.9%	22.4%	78.1%	0.0%	22.4%

Valuation
Metric	PLSE	XRAY	LMAT	ATRC	STAA	BLFS	Ind. Median
P/E	—	—	37.97	—	—	—	34.91
P/B	29.86	1.77●	5.83	3.17	4.01	3.72	2.95
EV/EBITDA	—	—	22.76●	60.24	—	—	14.72
P/S	2,636.18	0.63●	9.25	2.82	4.87	13.88	2.79

Financial Health
Metric	PLSE	XRAY	LMAT	ATRC	STAA	BLFS	Ind. Median
Current Ratio	7.26	1.53	14.32●	4.29	5.12	7.30	2.40
Debt/Equity	10.8%	176.9%	46.7%	15.2%	10.6%	4.0%●	34.8%
NetDebt/EBITDA	0.83	-16.86●	-1.84	-2.88	30.83	8.87	1.44

Profitability
Metric	PLSE	XRAY	LMAT	ATRC	STAA	BLFS	Ind. Median
Net Margin	-9,929.0%	-17.1%	24.3%●	-0.8%	-7.2%	-10.5%	3.9%
ROE	-80.7%	-37.7%	16.5%●	-1.0%	-6.0%	-2.9%	2.3%
ROA	-69.4%	-11.1%	10.5%●	-0.7%	-4.6%	-2.6%	1.5%
EBITDA Margin	-9,866.7%	-3.5%	37.6%●	4.5%	-1.4%	-7.5%	13.8%

Growth + Dividend
Metric	PLSE	XRAY	LMAT	ATRC	STAA	BLFS	Ind. Median
Rev. Growth	-69.9%	-1.0%	13.3%	15.0%	4.0%	40.9%●	6.4%
NI Growth	—	—	38.2%	—	—	—	14.0%
Div. Yield	—	4.3%●	0.9%	0.0%	—	—	1.7%
Payout	—	-20.4%	30.9%	0.0%	—	—	22.4%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on PLSE

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.